Mealey's (February 13, 2017, 2:10 PM EST) -- WASHINGTON, D.C. — A plaintiff on Feb. 3 asked the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize 18 federal cases in which plaintiffs alleged that they suffered diabetic ketoacidosis (DKA) or kidney injury from taking the diabetes drug Farxiga (In Re: Farxiga [Dapaglifozin] Products Liability Litigation, MDL Docket No. 2776, JPMDL)....